(Q43875168)

27 November 2017

title

Tacrolimus (FK506) in the treatment of prednisone-resistant myasthenia gravis. Preliminary results of 20 cases (English)

1 reference

27 November 2017

0 references

José M Ponseti

1

1 reference

27 November 2017

José M Fort

series ordinal

2

1 reference

27 November 2017

Eloy Espin

series ordinal

3

1 reference

27 November 2017

Manuel Armengol

series ordinal

4

1 reference

27 November 2017

language of work or name

Spanish

0 references

publication date

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

118

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

117

1 reference

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2972301-4

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2972301-4

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2972301-4

FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2972301-4

FK506 prevents induction of rat experimental autoimmune myasthenia gravis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2972301-4

10.1016/S0025-7753(02)72301-4

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference